Home Cart Sign in  
Chemical Structure| 3963-95-9 Chemical Structure| 3963-95-9

Structure of Methacycline HCl
CAS No.: 3963-95-9

Chemical Structure| 3963-95-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Methacycline HCl is a tetracycline antibiotic active against most Gram-positive bacteria and Gram-negative bacteria, acting through inhibiting the binding of aminoacyl-tRNA to the mRNA-ribosome complex thereby inhibiting protein synthesis.

Synonyms: Methacycline (hydrochloride); Rondomycin; 6-methylene Oxytetracycline

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Methacycline HCl

CAS No. :3963-95-9
Formula : C22H23ClN2O8
M.W : 478.88
SMILES Code : O=C(C1=C(O)[C@@H](N(C)C)[C@@]([C@@H](O)[C@@]2([H])C(C(C3=C(O)C=CC=C3C2=C)=O)=C4O)([H])[C@@]4(O)C1=O)N.[H]Cl
Synonyms :
Methacycline (hydrochloride); Rondomycin; 6-methylene Oxytetracycline
MDL No. :MFCD04972012
InChI Key :VXPSARQTYDZXAO-CCHMMTNSSA-N
Pubchem ID :54685047

Safety of Methacycline HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335-H351-H361
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary alveolar epithelial cells 5-10 µM 5 days Methacycline inhibited TGF-b1-induced EMT in primary alveolar epithelial cells, reducing the expression of α-smooth muscle actin, Snail1, and collagen I, and restoring cell border E-cadherin. PMC3930932
A549 cells 5 µM 48 h Methacycline inhibited TGF-b1-induced epithelial-mesenchymal transition (EMT) in A549 cells, restoring E-cadherin expression and suppressing fibronectin expression. PMC3930932
Escherichia coli Yale 25 µg/mL (MIC), 1,600 µg/mL (MBC) 24-48 h To compare the inhibitory effect of Methacycline on bacteria and their L-forms, results showed that L-forms were more susceptible than bacteria. PMC444306
Streptococcus faecalis GK 6.25 µg/mL (MIC), 800 µg/mL (MBC) 24-48 h To compare the inhibitory effect of Methacycline on bacteria and their L-forms, results showed that L-forms were more susceptible than bacteria. PMC444306
BeWo cells 20 μM 72 h To investigate the effect of Methacycline on mitochondrial oxidative phosphorylation capacity, results showed that Methacycline significantly reduced mitochondrial oxidative phosphorylation capacity. PMC6731647

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Bleomycin-induced pulmonary fibrosis model Intraperitoneal injection 100 mg/kg Once daily for 7 days Methacycline improved survival in bleomycin-induced pulmonary fibrosis mice and reduced the expression of collagen I, fibronectin, Snail1, and Twist1 in lung tissues. PMC3930932
Mice Systemic infection model Oral 10 mg/kg Every 12 hours for 48 hours To evaluate the therapeutic effect of plumbagin in combination with methacycline on tet(X4)-positive E. coli infection in mice, the results showed that the combination therapy significantly reduced bacterial load and alleviated pathological injury. PMC8933826

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02099240 Osteomyelitis Early Phase 1 Recruiting September 2019 United States, Kentucky ... More >> University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Julio A Ramirez, MD    502-852-1148    jarami01@louisville.edu    Contact: David Seligson, MD    502-852-0923    d0seli01@louisville.edu    Sub-Investigator: Forest Arnold, DO          Sub-Investigator: Timothy Wiemkwn, PhD          Sub-Investigator: Robert Kelley, PhD          Sub-Investigator: James Summersgill, PhD          Sub-Investigator: Ruth Carrico, PhD          Sub-Investigator: Julie Harting, PharmD          Sub-Investigator: Paula Peyrani, MD          Principal Investigator: David Seligson, MD          Sub-Investigator: Craig Roberts, MD          Principal Investigator: Julio Ramirez, MD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.09mL

0.42mL

0.21mL

10.44mL

2.09mL

1.04mL

20.88mL

4.18mL

2.09mL

References

 

Historical Records

Categories